Literature DB >> 114054

New long-acting injectable microcapsule contraceptive system.

L R Beck, D R Cowsar, D H Lewis, J W Gibson, C E Flowers.   

Abstract

A new long-acting, injectable contraceptive which provides continuous controlled release of the steroid norethisterone (NET) for a precise period of 6 months following a single intramuscular injection is described. The prototype system consists of microcapsules made of the biodegradable polymer d, l-polylactic acid, in which micronized crystals of NET are homogeneously dispersed. NET is slowly released from the microcapsules following intramuscular injection at a rate of 0.90 microgram NET/day/mg of microcapsule by diffusion of the steroid from the polymer matrix. Three different doses of a standard preparation of microcapsules were tested in normally cycling female babbons (4 to 5 baboons/group). Following injection of either 300, 200, or 100 mg of microcapsules containing 75, 50, or 25 mg of NET, blood samples were collected at selected intervals and analyzed for NET, estrogen, and progesterone by radioimmunoassay. All three doses provided continuous NET release for 6 months following injection. The NET serum profiles for the different doses are parallel, and ovulation was inhibited in all baboons for 6 months following treatment.

Entities:  

Keywords:  Animals, Laboratory; Biology; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--analysis; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--analysis; Contraceptive Agents--administraction and dosage; Contraceptive Agents--analysis; Contraceptive Methods; Endocrine System; Estrogens--analysis; Family Planning; Hormones; Injectables; Norethindrone--administraction and dosage; Norethindrone--analysis; Physiology; Progestational Hormones; Progesterone--analysis; Research Methodology

Mesh:

Substances:

Year:  1979        PMID: 114054     DOI: 10.1016/0002-9378(79)90717-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Poly(L-lactic acid) microspheres containing neutron-activatable holmium-165: a study of the physical characteristics of microspheres before and after irradiation in a nuclear reactor.

Authors:  R J Mumper; M Jay
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

Review 2.  Controlled-release delivery systems for hormones. A review of their properties and current therapeutic use.

Authors:  L R Beck; V Z Pope
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

3.  Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.

Authors:  Christian Wischke; Ying Zhang; Sachin Mittal; Steven P Schwendeman
Journal:  Pharm Res       Date:  2010-07-29       Impact factor: 4.200

4.  Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.

Authors:  T W Redding; A V Schally; T R Tice; W E Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

Review 5.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

6.  Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems.

Authors:  Dana da Silva; Maya Kaduri; Maria Poley; Omer Adir; Nitzan Krinsky; Janna Shainsky-Roitman; Avi Schroeder
Journal:  Chem Eng J       Date:  2018-01-03       Impact factor: 13.273

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.